Fill the program from the patients you already serve.
This category has real advertising restrictions, and the clinics that ignore them lose ad accounts. The launch plan starts where the demand already exists.
Your existing patient base is the first channel
A practice with an active patient list is starting from a position most new entrants would pay heavily for. The launch sequence is built around reactivation and introduction to patients who already trust the clinic — which is faster, cheaper, and considerably less regulated than acquiring strangers.
What the restrictions actually are
Compounded medications may not be advertised as safe, effective, or approved. Claims about specific clinical outcomes create real exposure for the clinic making them. Separately, the major advertising platforms restrict or prohibit this category under their own policies, and those policies change frequently and are enforced unevenly.
We build the plan around what a clinic can support compliantly and around channels that fit the category. We do not promise placement on any specific advertising platform, and any clinic that has been promised that should ask hard questions.
Acquisition, once the program is proven
Once the existing base is converting and the workflow holds, the plan extends to new patient acquisition — the channels, the messaging, and the intake routing, sequenced so the clinic is not buying attention it cannot yet serve.
Measurement
Early sales analysis in Days 31–60 and the performance review in Days 61–90 look at which offerings actually sell, which patients convert, and where the program is leaking — then the menu, pricing and messaging are adjusted against that rather than against assumption.
Launch Marketing questions.
Can you run ads for us?
Will our ads get approved?
Is it safe to email our existing patients about this?
Your patients are already asking about peptides.Make sure your clinic is ready to answer.
Build and launch your peptide program with Revival RX Partners in 90 days.
Important
- Revival RX Partners is a consulting and sourcing partner. It is not a pharmacy, does not compound or dispense medication, and does not practice medicine or provide medical advice.
- All medications are dispensed by licensed partner pharmacies against valid prescriptions issued by your clinic's licensed prescribers.
- Compounded peptides are not FDA-approved products. Availability, regulatory status, and pharmacy capability vary by compound and by state, and are subject to change.
- Nothing on this page is a guarantee of revenue, patient volume, or clinical outcomes. Revenue figures shown are illustrative and generated from values you enter.